Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BMN-190
print preview
bookmark
share with colleague
General Information
Company
BioMarin Pharmaceutical Inc.
Description
Tripeptidyl peptidase-1 (TPP1) enzyme replacement therapy
Molecular Target
Mechanism of Action
Enzyme replacement therapy
Latest Stage of Development
Preclinical
Indication
Neurology
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy